2015
DOI: 10.1177/1526602815573239
|View full text |Cite
|
Sign up to set email alerts
|

Initial Clinical Experience With the Zenith Alpha Stent-Graft

Abstract: The new Zenith Alpha appears to be equally as safe and efficacious as the Zenith TX-2 while being used in patients with demanding access vessel morphology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
11
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 29 publications
(43 reference statements)
2
11
1
Order By: Relevance
“…These results are favorable and/or comparable to what has been reported so far with other latest-generation or low-profile devices. There was no 30-day mortality as compared to 2.3%, 9% and 10% reported by other authors [20,22,23]. We saw no aortic rupture or stent fractures, again in line with the low incidences reported to date (1% and 1.1% for rupture and 0.9% for fracture) [20][21][22].…”
Section: Plos Onesupporting
confidence: 88%
See 1 more Smart Citation
“…These results are favorable and/or comparable to what has been reported so far with other latest-generation or low-profile devices. There was no 30-day mortality as compared to 2.3%, 9% and 10% reported by other authors [20,22,23]. We saw no aortic rupture or stent fractures, again in line with the low incidences reported to date (1% and 1.1% for rupture and 0.9% for fracture) [20][21][22].…”
Section: Plos Onesupporting
confidence: 88%
“…There were no adjunctive techniques in this series despite a mean access vessel diameter of 7.7 ± 1.32 mm (range 0.5-1); compared with 9.1 (6-13) mm previously reported with RelayPro [10]. Most patients had severe iliac and aortic tortuosity but there was no vessel-access related complication in this series, confirming a generally low incidence with all the low-profile devices reported so far: 3% [23], 5.7% [20], 6% [10] and 7% [22].…”
Section: Discussionsupporting
confidence: 68%
“…In our experience, the Zenith Alpha stent-graft could be implanted where previous attempts with other grafts had failed. 6 The rate of percutaneous access was markedly higher in our study compared to the TX-2 study (86.4% vs 2.5%). Moreover, the proportion of female patients was greater in our study (43.2% vs 28.1%).…”
Section: Discussioncontrasting
confidence: 61%
“…In patients with aortic aneurysms, narrow and calcified access vessels can lead to greater morbidity or even to treatment failure in standard-profile stent-grafts. 6 Moreover, compared with EVAR, the proportion of young, female, and Asian patients requiring TEVAR is greater. 3 As these patients have smaller access vessels, 4 this subgroup of patients is subjected to a higher incidence of access vessel complications and thus greater morbidity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation